Komori
Soiken Holdings (2385) · TargetReframed

Obtaining Approval to Label an Anti-Fatigue FOSHU Product

First written in FY2016. 3 of 5 entries say "Restated". Latest entry: FY2026.

5entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20232016: 12017: 020172018: 120182019: 020192020: 120202021: 020212022: 020222023: 120232024: 020242025: 020252026: 12026
Same theme, other companies
Obtaining Approval to Label an Anti-Fatigue FOSHU ProductA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「The Fatigue Project was undertaken to establish an assessment system for objectively evaluating and quantifying “fatigue” and to verify the effects of candidate anti-fatigue ingredients whose efficacy could not previously be assessed because no appropriate evaluation methods existed, with the aim of bringing anti-fatigue FOSHU products and pharmaceuticals to market.」

    The initiative is described as an R&D theme aimed at bringing anti-fatigue FOSHU products and pharmaceuticals into practical use, rather than solely as a goal of obtaining FOSHU approval.
  2. FY2023RestatedAnnual report

    「An anti-fatigue FOSHU product remains one of the Group's major targets and could also help revitalize the FOSHU market, so we will continue to take the best possible measures.」

    Even after filing applications for multiple anti-fatigue FOSHU products, obtaining approval to make the relevant label claims remains a major ongoing goal.
  3. FY2020RestatedAnnual report

    「An anti-fatigue FOSHU product remains one of the Group's major targets and could also help revitalize the FOSHU market, so we will continue to take the best possible measures.」

    Even after filing applications for multiple anti-fatigue FOSHU products, obtaining approval to make the relevant label claims remains a major ongoing goal.
  4. FY2018RestatedAnnual report

    「Applications have already been filed for several anti-fatigue FOSHU products. In addition, the Company and the researchers have jointly filed patent applications for many of the research成果 obtained through the “Study of the Molecular and Neural Mechanisms of Fatigue and Fatigue Sensation and Their Prevention.”」

    Several applications for anti-fatigue FOSHU products have been filed, while approval for an anti-fatigue FOSHU remains a major ongoing goal.
  5. FY2016First statedAnnual report

    「An anti-fatigue FOSHU product remains one of the Group's major targets and could also help revitalize the FOSHU market, so we will continue to take the best possible measures.」

    The Group aims to obtain approval for an anti-fatigue FOSHU product through the quantification of fatigue, verification of anti-fatigue ingredients, clinical trials and regulatory applications.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Soiken Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Obtaining Approval to Label an Anti-Fatigue FOSHU Product | Soiken Holdings Inc. (2385) | Komori